Sort
261,768 grants matching “gene therapy”
Regulation of Protein C Pathways
$944,019John H Griffin · Scripps Research Institute, The · R01 · FY2018 · HL
Regulation of Protein C Pathways
$944,019John H Griffin · Scripps Research Institute, The · R01 · FY2021 · HL
Molecular Pathogenesis of Acute Myeloid Leukemia
$944,000Timothy J Ley · Washington University · R35 · FY2022 · CA
3/7-PsycheMERGE: Advancing Precision Psychiatry
$943,999Roseann Elizabeth Peterson · Suny Downstate Medical Center · R01 · FY2025 · MH
Epigenetic and Genetic Control of Human and Murine Beta Cell Development and Fate
$943,959Seung K Kim · Stanford University · U01 · FY2012 · DK
Genetic Determinants of Epilepsy in Murine Systems
$943,906Tristan T Sands · Columbia University Health Sciences · R01 · FY2025 · NS
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$943,871Allan D. Kirk · Duke University · U01 · FY2017 · AI
CTRIP: Genetic Testing to Individualize Management of Common Heart Diseases
$943,853Gerald W. Dorn · Washington University · RC2 · FY2010 · HL
Metabolic Regulators of Tumor Growth and Progression
$943,806Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2021 · CA
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
$943,730Sulggi Angela Lee · University Of California, San Francisco · R61 · FY2021 · DA
APPROACHES TO THE ISOLATION OF SKIN TUMOR MODIFIER GENES
$943,593University Of California San Francisco · U01 · FY2002 · CA
GENETIC MODIFICATION OF STRIATED MUSCLES DURING AGING
$943,532University Of Michigan At Ann Arbor · P01 · FY2000 · AG
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$943,475Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2022 · AG
Preclinical development of Ala+TIMP-2 as an cancer therapeutic
$943,457William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$943,423Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Design And Development Of Experimental Therapeutics
$943,412Nigel H. Greig · National Institute On Aging · Z01 · FY2008 · AG
Therapeutic Strategies for the Management of HCV/HIV co- infection
$943,367Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Pre-clinical development of a small molecule therapeutic for the systemic treatment of idiopathic pulmonary fibrosis
$943,301Denis Evseenko · University Of Southern California · UG3 · FY2025 · AG
Determinants of Individual Differences in the Efficacy of Aerobic Exercise to Improve Brain Health and Reduce Alzheimer Disease Risk in Older African Americans
$943,193Mark A Gluck · Rutgers The State Univ Of Nj Newark · R01 · FY2023 · AG
Microarray and Genome Informatics
$943,144Pierre Bushel · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$943,101Alexander H. Stegh · Washington University · R01 · FY2025 · CA
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$943,099Antonio Fojo · Basic Sciences · Z01 · FY2007 · CA
Development of Novel Therapies for Acute Lymphoblastic Leukemia
$943,000Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Role of microRNAs in B-cell dysfunction in HIV/SIV infection
$942,811Mahesh Mohan · Texas Biomedical Research Institute · R01 · FY2020 · DA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2018 · CA